Skip to content
HowShorted

INOVIO PHARMACEUTICALS, INC. short interest in 2026

In 2026, INOVIO PHARMACEUTICALS, INC.'s disclosed short interest ran from 21.83% of shares outstanding on 15 Jan 2026 to 19.27% on 15 Sep 2026, a change of -2.56 percentage points. The year's high was 23.55% on 29 May 2026 and its low 14.31% on 31 Mar 2026, averaging 20.54% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.79 days on 13 Mar 2026. Full history: INOVIO PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for INOVIO PHARMACEUTICALS, INC. in 2026

2026 in figures

Start of year
21.83% (15 Jan 2026)
End of year
19.27% (15 Sep 2026)
Change
-2.56 pp
High
23.55% (29 May 2026)
Low
14.31% (31 Mar 2026)
Average
20.54%
Highest days to cover
14.79 (13 Mar 2026)
SEC filings marked
7

Every report in 2026

INOVIO PHARMACEUTICALS, INC. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202621.83%5.85
30 Jan 202623.24%12.53
13 Feb 202621.31%10.09
27 Feb 202620.46%14.39
13 Mar 202615.57%14.7910-K filed, results (8-K)
31 Mar 202614.31%12.04
15 Apr 202618.48%2.71
30 Apr 202620.60%9.80
15 May 202623.13%3.1710-Q filed, results (8-K)
29 May 202623.55%5.80
15 Jun 202623.45%10.78
30 Jun 202621.77%10.42
15 Jul 202621.09%9.17
31 Jul 202623.22%3.13results (8-K)
14 Aug 202619.31%3.7310-Q filed, results (8-K)
31 Aug 202618.62%4.36
15 Sep 202619.27%6.54

See also: INOVIO PHARMACEUTICALS, INC.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.